|
|
 |
|
Viewing report
|
|
|
|
Auxilium Pharmaceuticals, Inc.: SWOT Analysis & Company Profile
Business Review, Aug 2010, Pages: 26
Synopsis
Business Review’s Auxilium Pharmaceuticals, Inc. contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company.
Summary
This SWOT Analysis company profile is a crucial resource for industry executives and anyone looking to quickly understand the key information concerning Auxilium Pharmaceuticals, Inc.’s business.
Business Review’s “Auxilium Pharmaceuticals, Inc. SWOT Analysis & Company Profile” reports utilize a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.
Business Review strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
- Examines and identifies key information and issues about (Auxilium Pharmaceuticals, Inc.) for business intelligence requirements
- Studies and presents Auxilium Pharmaceuticals, Inc.’s strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
- The profile contains business operations, the company history, major products and services, prospects, key competitors, structure and key employees, locations and subsidiaries.
Reasons To Buy
- Quickly enhance your understanding of the company.
- Obtain details and analysis of the market and competitors as well as internal and external factors which could impact the industry.
- Increase business/sales activities by understanding your competitors’ businesses better.
- Recognize potential partnerships and suppliers.
- Obtain yearly profitability figures
Key Highlights
Auxilium Pharmaceuticals, Inc. (Auxilium) is a specialty biopharmaceutical company focused on the development and marketing of products for the treatment of urology and sexual health problems. The company’s products are marketed to urologists, endocrinologists, orthopedists and selected primary care physicians. It markets Testim, a proprietary, topical 1% testosterone once-a-day gel for the treatment of hypogonadism in men and XIAFLEX, for the treatment of Dupuytren's Contracture. Its XIAFLEX is also used for the treatment of Peyronie's disease and Frozen shoulder syndrome, therapy with one product for Overactive bladder and two products for pain designed using its transmucosal film delivery system. Auxilium is headquartered in Pennsylvania, the US.
|
|
|
|
